Lista de obras -

A custom-designed recombinant multiepitope protein as a dengue diagnostic reagent

artículo científico publicado en 2005

A repertoire of high-affinity monoclonal antibodies specific to S. typhi: as potential candidate for improved typhoid diagnostic

artículo científico publicado en 2015

A synthetic dengue virus antigen elicits enhanced antibody titers when linked to, but not mixed with, Mycobacterium tuberculosis HSP70 domain II.

artículo científico publicado en 2006

Adenovirus delivered short hairpin RNA targeting a conserved site in the 5' non-translated region inhibits all four serotypes of dengue viruses

artículo científico publicado en 2012

Adenovirus-vectored vaccines

artículo científico publicado en 2008

An adenovirus prime/plasmid boost strategy for induction of equipotent immune responses to two dengue virus serotypes

artículo científico publicado en 2007

An adenovirus type 5 (AdV5) vector encoding an envelope domain III-based tetravalent antigen elicits immune responses against all four dengue viruses in the presence of prior AdV5 immunity

artículo científico publicado en 2009

An envelope domain III-based chimeric antigen produced in Pichia pastoris elicits neutralizing antibodies against all four dengue virus serotypes.

artículo científico publicado en 2008

Ascorbate suppresses the opiate-induced compensatory increase in cyclic AMP in neuroblastoma × glioma hybrid cells ⬇️

artículo científico publicado el 15 de octubre de 1982

Casamino acids facilitate the secretion of recombinant dengue virus serotype-3 envelope domain III in Pichia pastoris

artículo científico publicado en 2016

Chimeric Hepatitis B core antigen virus-like particles displaying the envelope domain III of dengue virus type 2.

artículo científico publicado en 2012

Cissampelos pareira Linn: Natural Source of Potent Antiviral Activity against All Four Dengue Virus Serotypes

artículo científico publicado en 2015

Dengue vaccine efficacy trial: does interference cause failure?

artículo científico publicado en 2013

Dengue vaccines: state of the art.

artículo científico publicado en 2010

Dengue-specific subviral nanoparticles: design, creation and characterization

artículo científico publicado en 2013

Dengue: recent advances in biology and current status of translational research

artículo científico publicado en 2009

Double-Antigen Lateral Flow Immunoassay for the Detection of Anti-HIV-1 and -2 Antibodies Using Upconverting Nanoparticle Reporters

artículo científico publicado en 2021

Drugs for dengue: a patent review (2010-2014).

artículo científico publicado en 2014

Escherichia coli-expressed near full length HIV-1 envelope glycoprotein is a highly sensitive and specific diagnostic antigen

artículo científico publicado en 2012

Europium nanoparticle-based high performing immunoassay for the screening of treponemal antibodies

artículo científico publicado en 2013

Evaluation of a pan-serotype point-of-care rapid diagnostic assay for accurate detection of acute dengue infection.

artículo científico publicado en 2016

Evaluation of envelope domain III-based single chimeric tetravalent antigen and monovalent antigen mixtures for the detection of anti-dengue antibodies in human sera

artículo científico publicado en 2011

Expression, purification and characterization of in vivo biotinylated dengue virus envelope domain III based tetravalent antigen.

artículo científico publicado en 2010

High affinity mouse-human chimeric Fab against hepatitis B surface antigen

artículo científico publicado en 2005

High-level expression and one-step purification of recombinant dengue virus type 2 envelope domain III protein in Escherichia coli

artículo científico publicado en 2004

Induction of neutralizing antibodies and T cell responses by dengue virus type 2 envelope domain III encoded by plasmid and adenoviral vectors.

artículo científico publicado en 2006

Induction of neutralizing antibodies specific to dengue virus serotypes 2 and 4 by a bivalent antigen composed of linked envelope domains III of these two serotypes

artículo científico publicado en 2006

Inexpensive designer antigen for anti-HIV antibody detection with high sensitivity and specificity.

artículo científico publicado en 2010

Inhibition of hepatitis C virus replication by herbal extract: Phyllanthus amarus as potent natural source ⬇️

artículo científico publicado el 31 de marzo de 2011

Inhibition of preS1-hepatocyte interaction by an array of recombinant human antibodies from naturally recovered individuals

artículo científico publicado en 2016

Investigational drugs in early development for treating dengue infection.

artículo científico publicado en 2016

Novel membrane extraction procedure for the purification of hepatitis B surface antigen from Pichia pastoris ⬇️

artículo científico publicado el 1 de junio de 2012

Optimization of conditions for secretion of dengue virus type 2 envelope domain III using Pichia pastoris

artículo científico publicado en 2010

Photoaffinity labelling of the pea chloroplast transcriptional complex by nascent RNA in vitro ⬇️

artículo científico publicado el 25 de septiembre de 1991

Physiological response of Pichia pastoris GS115 to methanol-induced high level production of the Hepatitis B surface antigen: catabolic adaptation, stress responses, and autophagic processes

artículo científico publicado en 2012

Pichia pastoris-expressed dengue 2 envelope forms virus-like particles without pre-membrane protein and induces high titer neutralizing antibodies

artículo científico publicado en 2013

Pichia pastoris-expressed dengue 3 envelope-based virus-like particles elicit predominantly domain III-focused high titer neutralizing antibodies.

artículo científico publicado en 2015

Pichia pastoris-expressed dengue virus type 2 envelope domain III elicits virus-neutralizing antibodies.

artículo científico publicado en 2010

Recombinant Dengue Virus 4 Envelope Glycoprotein Virus-Like Particles Derived from Pichia pastoris are Capable of Eliciting Homotypic Domain III-Directed Neutralizing Antibodies.

artículo científico publicado en 2016

Recombinant multiepitope protein for early detection of dengue infections.

artículo científico publicado en 2006

Replication-Defective Adenoviral Vaccine Vector for the Induction of Immune Responses to Dengue Virus Type 2

artículo científico publicado en 2003

Simple high-cell density fed-batch technique for high-level recombinant protein production with Pichia pastoris: Application to intracellular production of Hepatitis B surface antigen

scientific article published on 10 February 2009

The identification of immunodominant linear epitopes of dengue type 2 virus capsid and NS4a proteins using pin-bound peptides.

artículo científico publicado en 2005

The prevalence of antibodies to adenovirus serotype 5 in an adult Indian population and implications for adenovirus vector vaccines

artículo científico publicado en 2010

Two distinct transcriptional activities of pea (Pisum sativum) chloroplasts share immunochemically related functional polypeptides ⬇️

artículo científico publicado el 15 de septiembre de 1992

Virus-like particle production with yeast: ultrastructural and immunocytochemical insights into Pichia pastoris producing high levels of the hepatitis B surface antigen

artículo científico publicado en 2011

Virus-like particles derived from Pichia pastoris-expressed dengue virus type 1 glycoprotein elicit homotypic virus-neutralizing envelope domain III-directed antibodies

artículo científico publicado en 2016

Virus-like particles displaying envelope domain III of dengue virus type 2 induce virus-specific antibody response in mice

artículo científico publicado en 2012

Lista de obras de

A custom-designed recombinant multiepitope protein as a dengue diagnostic reagent

A repertoire of high-affinity monoclonal antibodies specific to S. typhi: as potential candidate for improved typhoid diagnostic

A synthetic dengue virus antigen elicits enhanced antibody titers when linked to, but not mixed with, Mycobacterium tuberculosis HSP70 domain II.

Adenovirus delivered short hairpin RNA targeting a conserved site in the 5' non-translated region inhibits all four serotypes of dengue viruses

Adenovirus-vectored vaccines

An adenovirus prime/plasmid boost strategy for induction of equipotent immune responses to two dengue virus serotypes

An adenovirus type 5 (AdV5) vector encoding an envelope domain III-based tetravalent antigen elicits immune responses against all four dengue viruses in the presence of prior AdV5 immunity

An envelope domain III-based chimeric antigen produced in Pichia pastoris elicits neutralizing antibodies against all four dengue virus serotypes.

Ascorbate suppresses the opiate-induced compensatory increase in cyclic AMP in neuroblastoma × glioma hybrid cells ⬇️

Casamino acids facilitate the secretion of recombinant dengue virus serotype-3 envelope domain III in Pichia pastoris

Chimeric Hepatitis B core antigen virus-like particles displaying the envelope domain III of dengue virus type 2.

Cissampelos pareira Linn: Natural Source of Potent Antiviral Activity against All Four Dengue Virus Serotypes

Dengue vaccine efficacy trial: does interference cause failure?

Dengue vaccines: state of the art.

Dengue-specific subviral nanoparticles: design, creation and characterization

Dengue: recent advances in biology and current status of translational research

Double-Antigen Lateral Flow Immunoassay for the Detection of Anti-HIV-1 and -2 Antibodies Using Upconverting Nanoparticle Reporters

Drugs for dengue: a patent review (2010-2014).

Escherichia coli-expressed near full length HIV-1 envelope glycoprotein is a highly sensitive and specific diagnostic antigen

Europium nanoparticle-based high performing immunoassay for the screening of treponemal antibodies

Evaluation of a pan-serotype point-of-care rapid diagnostic assay for accurate detection of acute dengue infection.

Evaluation of envelope domain III-based single chimeric tetravalent antigen and monovalent antigen mixtures for the detection of anti-dengue antibodies in human sera

Expression, purification and characterization of in vivo biotinylated dengue virus envelope domain III based tetravalent antigen.

High affinity mouse-human chimeric Fab against hepatitis B surface antigen

High-level expression and one-step purification of recombinant dengue virus type 2 envelope domain III protein in Escherichia coli

Induction of neutralizing antibodies and T cell responses by dengue virus type 2 envelope domain III encoded by plasmid and adenoviral vectors.

Induction of neutralizing antibodies specific to dengue virus serotypes 2 and 4 by a bivalent antigen composed of linked envelope domains III of these two serotypes

Inexpensive designer antigen for anti-HIV antibody detection with high sensitivity and specificity.

Inhibition of hepatitis C virus replication by herbal extract: Phyllanthus amarus as potent natural source ⬇️

Inhibition of preS1-hepatocyte interaction by an array of recombinant human antibodies from naturally recovered individuals

Investigational drugs in early development for treating dengue infection.

Novel membrane extraction procedure for the purification of hepatitis B surface antigen from Pichia pastoris ⬇️

Optimization of conditions for secretion of dengue virus type 2 envelope domain III using Pichia pastoris

Photoaffinity labelling of the pea chloroplast transcriptional complex by nascent RNA in vitro ⬇️

Physiological response of Pichia pastoris GS115 to methanol-induced high level production of the Hepatitis B surface antigen: catabolic adaptation, stress responses, and autophagic processes

Pichia pastoris-expressed dengue 2 envelope forms virus-like particles without pre-membrane protein and induces high titer neutralizing antibodies

Pichia pastoris-expressed dengue 3 envelope-based virus-like particles elicit predominantly domain III-focused high titer neutralizing antibodies.

Pichia pastoris-expressed dengue virus type 2 envelope domain III elicits virus-neutralizing antibodies.

Recombinant Dengue Virus 4 Envelope Glycoprotein Virus-Like Particles Derived from Pichia pastoris are Capable of Eliciting Homotypic Domain III-Directed Neutralizing Antibodies.

Recombinant multiepitope protein for early detection of dengue infections.

Replication-Defective Adenoviral Vaccine Vector for the Induction of Immune Responses to Dengue Virus Type 2

Simple high-cell density fed-batch technique for high-level recombinant protein production with Pichia pastoris: Application to intracellular production of Hepatitis B surface antigen

The identification of immunodominant linear epitopes of dengue type 2 virus capsid and NS4a proteins using pin-bound peptides.

The prevalence of antibodies to adenovirus serotype 5 in an adult Indian population and implications for adenovirus vector vaccines

Two distinct transcriptional activities of pea (Pisum sativum) chloroplasts share immunochemically related functional polypeptides ⬇️

Virus-like particle production with yeast: ultrastructural and immunocytochemical insights into Pichia pastoris producing high levels of the hepatitis B surface antigen

Virus-like particles derived from Pichia pastoris-expressed dengue virus type 1 glycoprotein elicit homotypic virus-neutralizing envelope domain III-directed antibodies

Virus-like particles displaying envelope domain III of dengue virus type 2 induce virus-specific antibody response in mice